EpiStem - Press Releases
Epistem to Provide Preclinical Efficacy Testing Services for Exponential Biotherapies
19 May 2008 09:30
Epistem and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
19 May 2008 09:27
Epistem to release data on it's Cancer Stem Cell Assays at AACR
19 May 2008 09:23
EpiStem's Radiation Damage Models for Intestinal Stem Cells Chosen by NIH Biodefence Programme
22 Nov 2006 11:33
Applied Imaging Completes the First Custom Installation of Ariol® Image-Analysis System at Preclinical Research Provider EpiStem, Ltd
31 May 2006 16:53
Callisto Pharmaceuticals Selects EpiStem to Provide Specialised Preclinical Efficacy Testing for Guanilib, its Lead Drug Candidate for IBD
09 May 2006 10:51
19 May 2008 09:30
Epistem and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
19 May 2008 09:27
Epistem to release data on it's Cancer Stem Cell Assays at AACR
19 May 2008 09:23
EpiStem's Radiation Damage Models for Intestinal Stem Cells Chosen by NIH Biodefence Programme
22 Nov 2006 11:33
Applied Imaging Completes the First Custom Installation of Ariol® Image-Analysis System at Preclinical Research Provider EpiStem, Ltd
31 May 2006 16:53
Callisto Pharmaceuticals Selects EpiStem to Provide Specialised Preclinical Efficacy Testing for Guanilib, its Lead Drug Candidate for IBD
09 May 2006 10:51
